Keywords: Israel, Pharmaceutical market, Forecasts, Foreign investment

Cost-containment and imports will restrain Israel Pharma market growth

Article | 28 April 2010

The Israeli pharmaceutical market, worth some 6.15 billion Israeli shekels ($1.59 billion) in 2009, is forecast to grow marginally in the medium term, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in